Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1976 Feb;73(2):643–645. doi: 10.1073/pnas.73.2.643

Antagonism of 5-hydroxykynurenamine against serotonin action on platelet aggregation.

M Okuma, T Tokuyama, S Senoh, F Hirata, O Hayaishi
PMCID: PMC335967  PMID: 1061163

Abstract

Serotonin induced an aggregation of human platelets, whereas 5-hydroxykynurenamine, produced from serotonin by the action of indoleamine 2,3-dioxygenase, did not cause any significant degree of platelet aggregation. 5-Hydroxykynurenamine specifically inhibited both a serotonin-induced aggregation of platelets and the potentiation of the ADP-induced platelet aggregation by serotonin. It did not, however, alter the profiles of the platelet aggregation induced by ADP, collagen, or adrenaline. The degree of inhibition was proportional to the time of preincubation of platelets with 5-hydroxykynurenamine, and to the concentration of 5-hydroxykynurenamine used. Available evidence indicated that 5-hydroxykynurenamine completed with serotonin for the same receptor sites. Studies with analogues of 5-hydroxykynurenamine indicated that the substitutions of 0-amino-benzyl moiety with hydroxy or methoxy groups were somewhat tolerated, whereas the masking of alkylamine moiety with N-acetylation completely lost the inhibitory activity.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baumgartner H. R., Born G. V. Effects of 5-hydroxytryptamine on platelet aggregation. Nature. 1968 Apr 13;218(5137):137–141. doi: 10.1038/218137a0. [DOI] [PubMed] [Google Scholar]
  2. Hirata F., Hayaishi O. New degradative routes of 5-hydroxytryptophan and serotonin by intestinal tryptophan 2,3-dioxygenase. Biochem Biophys Res Commun. 1972 Jun 9;47(5):1112–1119. doi: 10.1016/0006-291x(72)90949-7. [DOI] [PubMed] [Google Scholar]
  3. Hirata F., Hayaishi O., Tokuyama T., Seno S. In vitro and in vivo formation of two new metabolites of melatonin. J Biol Chem. 1974 Feb 25;249(4):1311–1313. [PubMed] [Google Scholar]
  4. Kido R., Noguchi T., Tsuji T., Matsumura Y. The identification of 4, 6-quinolinediol and 4,8-quinolinediol in the urine of hens. Biochim Biophys Acta. 1967 Feb 7;136(1):131–135. doi: 10.1016/0304-4165(67)90328-5. [DOI] [PubMed] [Google Scholar]
  5. Michal F., Penglis F. Inhibition of serotonin-induced platelet aggregation in relation to thrombus production. J Pharmacol Exp Ther. 1969 Apr;166(2):276–284. [PubMed] [Google Scholar]
  6. Okuma M., Steiner M., Baldini G. Studies on lipid peroxides in platelets. II. Effect of aggregating agents and platelet antibody. J Lab Clin Med. 1971 May;77(5):728–742. [PubMed] [Google Scholar]
  7. Toda N., Tokuyama T., Seno S., Hirata F., Hayaishi O. Effects of 5-hydroxykynurenamine, a new serotonin metabolite, on isolated dog basilar arteries. Proc Natl Acad Sci U S A. 1974 Jan;71(1):122–124. doi: 10.1073/pnas.71.1.122. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES